2,449
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Synthesis, characterization and evaluation of tinidazole-loaded mPEG–PDLLA (10/90) in situ gel forming system for periodontitis treatment

, &
Pages 2726-2735 | Received 28 Apr 2015, Accepted 08 Jun 2015, Published online: 07 Aug 2015

References

  • Ahmed AR, Dashevsky A, Bodmeier R. (2008). Reduction in burst release of PLGA microparticles by incorporation into cubic phase-forming systems. Eur J Pharm Biopharm 70:765–9
  • Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123–33
  • Do MP, Neut C, Delcourt E, et al. (2014). In situ forming implants for periodontitis treatment with improved adhesive properties. Eur J Pharm Biopharm 88:342–50
  • Egelberg J, Attström R. (1973). Comparison between orifice and intracrevicular methods of sampling gingival fluid. J Periodontal Res 8:384–8
  • Eke PI, Dye BA, Wei L, et al. (2012). Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 91:914–20
  • Gad HA, El-Nabarawi MA, Abd El-Hady SS. (2008). Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis. AAPS PharmSciTech 9:878–84
  • Hasturk H, Goguet-Surmenian E, Blackwood A, et al. (2009). 1-Tetradecanol complex: therapeutic actions in experimental periodontitis. J Periodontol 80:1103–13
  • Hosadurga RR, Rao SN, Jose J, et al. (2014). Evaluation of the efficacy of 2% curcumin gel in the treatment of experimental periodontitis. Pharmacogn Res 6:326–33
  • Ito H, Numabe Y, Sekino S, et al. (2014). Evaluation of bleeding on probing and gingival crevicular fluid enzyme activity for detection of periodontally active sites during supportive periodontal therapy. Odontology 102:50–6
  • Kang F, Singh J. (2005). In vitro release of insulin and biocompatibility of in situ forming gel systems. Int J Pharm 304:83–90
  • Labib GS, Aldawsari HM, Badr-Eldin SM. (2014). Metronidazole and Pentoxifylline films for the local treatment of chronic periodontal pockets: preparation, in vitro evaluation and clinical assessment. Expert Opin Drug Deliv 11:855–65
  • Maestre JR, Bascones A, Sánchez P, et al. (2007). Odontogenic bacteria in periodontal disease and resistance patterns to common antibiotics used as treatment and prophylaxis in odontology in Spain. Rev Esp Quimioter 20:61–7
  • Mahadlek J, Charoenteeraboon J, Phaechamud T. (2013). Benzoyl peroxide in situ forming antimicrobial gel for periodontitis treatment. Key Eng Mater 545:63–8
  • Mownika G, Srinivas P. (2012). Formulation and evaluation of simvastatin injectable in situ implants. Am J Drug Discov Dev 2:87–100
  • Reise M, Wyrwa R, Müller U, et al. (2012). Release of metronidazole from electrospun poly (l-lactide-co-d/l-lactide) fibers for local periodontitis treatment. Dent Mater 28:179–88
  • Sandker MJ, Petit A, Redout EM, et al. (2013). In situ forming acyl-capped PCLA–PEG–PCLA triblock copolymer based hydrogels. Biomaterials 34:8002–11
  • Schwach-Abdellaoui K, Vivien-Castioni N, Gurny R. (2000). Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm 50:83–99
  • Seo BM, Miura M, Gronthos S, et al. (2004). Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 364:149–55
  • Shi J, Zhang J, Shen Y, et al. (2015). Arginine-stabilized mPEG–PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery. Drug Deliv 22:168–81
  • Socransky SS, Haffajee AD. (1994). Evidence of bacterial etiology: a historical perspective. Periodontology 2000 5:7–25
  • Walker C, Karpinia K. (2002). Rationale for use of antibiotics in periodontics. J Periodontol 73:1188–96
  • Wood BA, Faulkner JK, Monro AM. (1982). The pharmacokinetics, metabolism and tissue distribution of tinidazole. J Antimicrob Chemother 10:43–57
  • Wüst J. (1977). Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods. Antimicrob Agents Chemother 11:631–7
  • Yang H, Kao WJ. (2006). Thermoresponsive gelatin/monomethoxy poly(ethylene glycol)–poly(d,l-lactide) hydrogels: formulation, characterization, and antibacterial drug delivery. Pharm Res 23:205–14
  • Yao DG, Sun KX, Mu HJ, et al. (2009). Preparation of cyclosporine A loaded mPEG–PLGA copolymer micelles and study its pharmacokinetics in rats. Yao Xue Xue Bao = Acta Pharm Sin 44:1410–15
  • Zamani M, Morshed M, Varshosaz J, et al. (2010). Controlled release of metronidazole benzoate from poly epsilon-caprolactone electrospun nanofibers for periodontal diseases. Eur J Pharm Biopharm 75:179–85
  • Zhang X, Jackson JK, Burt HM. (1996). Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm 132:195–206
  • Zhang Y, Huo M, Zhou J, et al. (2010). DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 12:263–71
  • Zhou X, Fu CM, He Y, et al. (2010). In vitro balanced sustained-release of Panax notoginseng saponins controlled with various matrix materials. Acta Pharm Sin 45:505–9
  • Zhu J, Jiang P, Yan H, et al. (2010). Preparation and evaluation of pilocarpine nitrate in situ gel for ophthalmic use. Chin Tradit Herbal Drugs 41:720–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.